Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Tax Provisions (2020 - 2022)

Rani Therapeutics Holdings' Tax Provisions history spans 3 years, with the latest figure at -$11000.0 for Q4 2022.

  • On a quarterly basis, Tax Provisions rose 72.5% to -$11000.0 in Q4 2022 year-over-year; TTM through Dec 2023 was -$11000.0, a 111.0% decrease, with the full-year FY2022 number at $100000.0, up 143.9% from a year prior.
  • Tax Provisions came in at -$11000.0 for Q4 2022, up from -$106000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $154000.0 in Q2 2022, with the low at -$106000.0 in Q3 2022.
  • Historically, Tax Provisions has averaged $14909.1 across 3 years, with a median of $6000.0 in 2020.
  • Biggest five-year swings in Tax Provisions: crashed 433.33% in 2021 and later skyrocketed 15300.0% in 2022.
  • Year by year, Tax Provisions stood at $12000.0 in 2020, then tumbled by 433.33% to -$40000.0 in 2021, then skyrocketed by 72.5% to -$11000.0 in 2022.
  • Business Quant data shows Tax Provisions for RANI at -$11000.0 in Q4 2022, -$106000.0 in Q3 2022, and $154000.0 in Q2 2022.